Table 2.

Frontline therapy in breast cancer before and during lockdown

Front-line therapy in breast cancer (n=552)
Parameter	Before lockdown (March 16, 2019 to May 31, 2019)	During lockdown (March 16, 2020 to May 31, 2020)	Difference (%)	P value
Primary surgery	238 (68%)	102 (51%)	−17%	<0.001*
Neoadjuvant chemotherapy	77 (22%)	81 (40%)	+18%
Neoadjuvant endocrine therapy	27 (8%)	16 (8%)	0%
No therapy	9 (2%)	2 (1%)	−1%
Total	351	201

*χ² test.